Acumen Hypotension Prediction Index – EV1000 Clinical Platform vs TeraRecon Cardiovascular.Calcification.CT

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Acumen Hypotension Prediction Index – EV1000 Clinical Platform
by Edwards Lifesciences
VS
TeraRecon Cardiovascular.Calcification.CT
by TeraRecon

AI Verdict

Tool A is designed for real-time prediction and management of intraoperative hypotension using continuous hemodynamic monitoring. In contrast, Tool B specializes in the automated analysis of CT images to detect and quantify coronary artery calcifications for diagnostic and pre-operative planning purposes. While both fall under Cardiology AI, their distinct focus on dynamic physiological prediction versus static image-based diagnosis makes them suitable for different clinical scenarios.

Choose Acumen Hypotension Prediction Index – EV1000 Clinical Platform if…

Choose the Acumen Hypotension Prediction Index if your primary goal is real-time, proactive management of hemodynamic stability in surgical or critical care environments. This tool is ideal for clinicians who need to anticipate and intervene to prevent hypotensive events up to 15 minutes in advance, leveraging continuous hemodynamic monitoring and machine learning insights into preload, afterload, and contractility.

View Acumen Hypotension Prediction Index – EV1000 Clinical Platform →

Choose TeraRecon Cardiovascular.Calcification.CT if…

Choose TeraRecon Cardiovascular.Calcification.CT if you require automated, precise analysis of CT images for cardiovascular risk assessment and pre-operative planning. This software is best suited for radiologists and cardiologists who need to accurately detect, segment, and quantify coronary artery calcifications, providing essential data for calcium scoring systems and detailed vessel analysis.

View TeraRecon Cardiovascular.Calcification.CT →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform TeraRecon Cardiovascular.Calcification.CT
Deployment On-premise (integrated with EV1000 clinical platform and HemoSphere advanced monitoring platform) Cloud-enabled imaging platform.
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Acumen HPI is integrated into the Edwards Lifesciences HemoSphere Advanced Monitoring Platform, providing continuous, real-time insights at the patient's bedside. Its 'Smart Alerts' and 'Relationship View' are designed for immediate clinical action in critical care settings, making it highly usable for its target audience of anesthesiologists and critical care staff.

Clinical Value

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Acumen HPI offers real-time predictive analytics for hypotensive events up to 15 minutes in advance, providing crucial insights into hemodynamic instability and potential causes. This proactive approach allows for early intervention, which can significantly improve patient outcomes and reduce complications in acute care settings.

Pricing & Value

TeraRecon Cardiovascular.Calcification.CT

TeraRecon Cardiovascular.Calcification.CT offers a transparent subscription-based pricing model with a single annual fee, which eliminates annual service renewals and provides operational budget flexibility. In contrast, Acumen HPI requires contacting the vendor for pricing, offering less upfront clarity on cost structure.

Enterprise Readiness

TeraRecon Cardiovascular.Calcification.CT

Both tools are HIPAA compliant and FDA cleared. However, TeraRecon Cardiovascular.Calcification.CT is deployed as a containerized application (SaMD) or SaaS within the Eureka Clinical AI platform, offering greater flexibility for IT integration into diverse hospital environments. The explicit mention of a Business Associate Agreement (BAA) further reinforces its enterprise readiness for secure data handling.

Innovation

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Acumen HPI's core innovation lies in its machine learning-based algorithm that predicts hypotensive events up to 15 minutes in advance, enabling a shift from reactive to proactive patient management in critical care. This real-time predictive capability for immediate physiological intervention represents a significant advancement in patient safety.

Support & Docs

Tie

Both Edwards Lifesciences and TeraRecon are established medical technology companies with comprehensive support structures. While specific comparative details on documentation and support services for these particular tools are not provided in the structured facts, both companies offer technical support, customer service, and educational resources.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform TeraRecon Cardiovascular.Calcification.CT
Name Acumen Hypotension Prediction Index u2013 EV1000 Clinical Platform TeraRecon Cardiovascular.Calcification.CT
Company Edwards Lifesciences Terarecon
Primary Function Uses machine learning to predict hypotensive events up to 15 minutes in advance, providing insights into hemodynamic instability. AI-powered software that analyzes CT images to automatically detect and measure calcifications in the coronary arteries.
Primary AI Application Category Cardiology AI, Surgical AI, Triage & ER/ICU AI Cardiology AI
Key Clinical Output HPI Parameter (0-100 likelihood score), Smart Alerts for trending hypotension, Relationship View screen (preload, afterload, contractility insights). Automatic 3D segmentation of calcified plaques in coronary arteries, outputs mask for calcium scoring systems (Agatston score, volume, mean mass).
Prediction/Analysis Type Predicts hypotension up to 15 minutes in advance, continuous hemodynamic monitoring. Automatic detection and measurement of calcifications in coronary arteries from CT images.

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform and TeraRecon Cardiovascular.Calcification.CT.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tool A, Acumen HPI, integrates with Edwards Lifesciences HemoSphere Advanced Monitoring Platform via dedicated sensors for continuous hemodynamic monitoring, providing real-time data. Tool B, TeraRecon Cardiovascular.Calcification.CT, is a software as a medical device (SaMD) available as a containerized application or SaaS within the Eureka Clinical AI platform, designed to integrate with PACS for image analysis and potentially EHR systems for reporting.
Acumen HPI software demonstrated high accuracy in predicting hypotension, with an internal validation of 350 patient records showing 89% specificity and 90% sensitivity at 10 minutes before an event, and an AUC of 0.95. TeraRecon Cardiovascular.Calcification.CT automatically detects and measures calcifications in coronary arteries, providing a mask for calcium scoring systems, supporting Agatston score, volume, and mean mass measurements.
Acumen HPI offers clinical utility in anesthesiology, critical care, and emergency medicine by predicting hypotensive events up to 15 minutes in advance, aiming to reduce intraoperative hypotension. TeraRecon Cardiovascular.Calcification.CT provides value to cardiology, cardiothoracic surgery, and radiology by automating the detection and measurement of coronary artery calcifications for risk assessment and surgical planning.
Acumen HPI provides a likelihood score (0-100) and insights into hemodynamic instability, requiring clinicians to interpret real-time data and smart alerts. TeraRecon's platform prioritizes clinician satisfaction with intuitive workflows and customizable templates, suggesting a focus on ease of use for image analysis and reporting.
Rolling out Acumen HPI involves integrating with existing Edwards Lifesciences HemoSphere platforms and deploying dedicated sensors (Acumen IQ cuff or sensor) across sites. TeraRecon Cardiovascular.Calcification.CT, as a containerized application or SaaS within Eureka Clinical AI, offers flexibility and scalability for enterprise environments, supporting unified management of multiple AI algorithms.
Edwards Lifesciences provides customer service and support for Acumen HPI, including technical support. TeraRecon offers clearly defined support channels, including phone, email, user manuals, and a 'Premier Success' program with dedicated customer success managers and an e-learning center, and highlights customer testimonials.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform or TeraRecon Cardiovascular.Calcification.CT

AI Tool Finder
AI-powered search. Results may not be comprehensive.